bilastine
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Blexten, others |
| Pregnancy category |
|
| Routes of administration | By mouth |
| Drug class | Antihistamine |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 61% |
| Protein binding | 84-90% binding to plasma proteins |
| Metabolism | Not significantly metabolised |
| Onset of action | 1 hour (Allertine) |
| Elimination half-life | 14.5 hours |
| Duration of action | 24 hours (Allertine) |
| Excretion | 95% in urine and faeces |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C28H37N3O3 |
| Molar mass | 463.622 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
bilastine (tsz. bilastines)